Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | THRB | P10828 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | RARB | P10826 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | GBA2 | Q9HCG7 | 6/20 | 0.33 |
| ▸ | GBA1 | P04062 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3392777 | 1.00 | MEN1 (0.56) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL2367446 | 1.00 | MEN1 (0.56) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL2247227 | 1.00 | MEN1 (0.56) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL31146729 | 1.00 | MEN1 (0.56) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL31146793 | 1.00 | MEN1 (0.56) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL1034519 | 1.00 | MEN1 (0.56) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL2244270 | 1.00 | MEN1 (0.56) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL16593815 | 1.00 | MEN1 (0.56) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL9403613 | 0.98 | MEN1 (0.59) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL2127384 | 0.98 | MEN1 (0.59) | MEN1KMT2ATHRBHTTMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4164564-A | MINERAL OIL, ESTERS OF ISOSTEARIC ACID | E. R. SQUIBB & SONS, INC. (US) | 1979-08-14 | — | — | US | claimed |
| CN-106456516-B | Composition in form of nanoemulsion or microemulsion | 莱雅公司 | 2020-09-29 | — | — | CN | disclosed |
| US-9757701-B2 | Method for producing oil-in-water emulsions from self-emulsifying gel concentrates | SASOL GERMANY GMBH (DE) | 2017-09-12 | — | — | US | disclosed |
| US-20110033555-A1 | METHOD FOR PRODUCING WAX IN WATER DISPERSIONS FROM SELF-EMULSIFYING GEL CONCENTRATES | KWETKAT KLAUS | 2011-02-10 | — | — | US | disclosed |
| US-20110033413-A1 | METHOD FOR PRODUCING OIL-IN-WATER EMULSIONS FROM SELF-EMULSIFYING GEL CONCENTRATES | KWETKAT KLAUS | 2011-02-10 | — | — | US | disclosed |
| CN-1385457-A | Gel composition | PANRICO PARTNERSHIP INC (US) | 2002-12-18 | — | — | CN | disclosed |
| CN-1348815-A | Medicine for preventing and treating coronary heart disease and angina pectoris and its prepn and other use | TIANJIN TIANSHILI PHARMACEUTIC (CN) | 2002-05-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110033555-A1 | METHOD FOR PRODUCING WAX IN WATER DISPERSIONS FROM SELF-EMULSIFYING GEL CONCENTRATES | LSS, LIPA, ERG28 | MEN1 4612/4885KMT2A 4672/4885THRB 4722/4885 |
| US-20110033413-A1 | METHOD FOR PRODUCING OIL-IN-WATER EMULSIONS FROM SELF-EMULSIFYING GEL CONCENTRATES | LIPA, CCNO, CEL | MEN1 4160/4885KMT2A 4546/4885THRB 4663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.